Stephen is Chief Executive Officer of IHMA Europe Sàrl based in Switzerland, a wholly owned affiliate of International Health Management Associates.

Since it began operating in 2009, under Stephen’s leadership, IHMA has focused on providing a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization.

Before joining IHMA, Stephen held several key positions in the pharmaceutical industry spanning 15 years, focused on antibacterial and antifungal research and development. Stephen has worked at Arpida, GlaxoWellcome, Hoechst Marion Roussel and Marion Merrell Dow.

Stephen has either written or co-written over 90 internationally peer-reviewed publications, has had about 700 posters published at scientific conferences and regularly reviews manuscripts for multiple journals. He is also co-inventor of a number of patents. He has actively participated in Clinical & Laboratory Standards Institute meetings for more than 15 years.

Stephen earned his BSc (Hons) in microbiology from the University of Aberdeen, his PhD in biochemical toxicology from the University of Dundee and did his post-doctorate on fungal catheter biofilms at the University of Glasgow.